Ustekinumab is currently the only anti-interleukin therapy approved for the treatment of ulcerative colitis, but given the superior performance of risankizumab in CD patients, it will be interesting to see data regarding its efficacy in UC.

Jeff R. Peterson, MD

Keith C. Ferdinand, MD, Tulane University School of Medicine

Jane Davis, DNP

Latest Article

Sick Day Rules in Nephrology, with Kim Zuber, PA-C, and Jane Davis, DNP

3 years ago

In their latest column, Kim Zuber, PA-C, and Jane Davis, DNP, break down the concept of "sick day rules" and what this means for providers caring for those with kidney disease.

Sophia Abene

Latest Article

The Long COVID Patient Journey: A Complex and Uncertain Road

2 years ago

Navigating the long road of Long COVID requires more than just recovery from an infection, it demands specialized, multifaceted care to address persistent and often invisible neurological symptoms.

Meg Dalton

Writer at Yale University

Latest Article

The cure for cystic fibrosis might start in the womb

a year ago

In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.

Mallory Locklear, PhD

Managing Editor—Science, Research, and Education at Yale School of Medicine.

Latest Article

How an Essential Vitamin B-Derived Nutrient Concentrates in Mitochondria

a year ago

Yale researchers reveal how essential coenzyme A is imported into mitochondria, shedding light on its role in metabolic diseases and potential treatments.